Blenrep patient Ambassador

DIGITAL: GSK launched a NEW first-in-class treatment for Relapsed or Refractory Multiple Myeloma in August 2020. To support this launch, we created a branded patient ambassador program to support patients starting and continuing treatment on BLENREP. This program aimed to inform patients of the benefit/risk profile of BLENREP, instill confidence, and encourage discussion of BLENREP with the patient’s care team.

Produced by Area23

Meet Kathy!

Kathy animated

Kathy Long Form Storyboard

Kathy Animation Storyboard

Meet Cynthia!

Cynthia Long Form Stortyboard